Company / Income Tax per Share
Vir Biotechnology, Inc. Income Tax per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.00
FY2025
5-year range
-$0.10 / $0.00
FY2021-FY2025
Trend
+118.7%
vs FY2024
Sector context
#102 of 201
Health Care
What the data says
At $0.00, Vir Biotechnology, Inc.'s income tax per share ranks #100 of 201 in the Health Care sector. Income Tax per Share has fluctuated over the past 9 years, ranging from $-5.08 in FY2017 to $0.02 in FY2019.
Based on SEC 10-K filings.
0.00 in FY2025 with a 5-year CAGR of +25.9%.
Increased from $-0.10 to $0.00 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- +56.7%
- 5-Year CAGR
- +25.9%
- 10-Year CAGR
- -
Sector benchmark
#100 of 201 in Health CareTop 49% of 201This company $0.00 Sector average $1.35
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2025, income tax per share increased 118.7% year-over-year.
- Ranks #102 out of 201 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2019.
- Lowest income tax per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | +118.7% |
| FY2024 | -$0.01 | +91.3% |
| FY2023 | -$0.10 | -23939.5% |
| FY2022 | $0.00 | -65.9% |
| FY2021 | $0.00 | +140.9% |
| FY2020 | $0.00 | -97.1% |
| FY2019 | $0.02 | +127.8% |
| FY2018 | -$0.06 | +98.8% |
| FY2017 | -$5.08 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026